HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.
Paul J ColliniMartin A BewleyMohamed MohasinHelen M MarriottRobert F MillerAnna-Maria GerettiApostolos BeloukasAthanasios PapadimitropoulosRobert C ReadMahdad NoursadeghiDavid H DockrellPublished in: American journal of respiratory and critical care medicine (2019)
Despite ART, HIV-1, via gp120, drives persisting innate immune defects in AM microbicidal mechanisms, enhancing susceptibility to pneumococcal disease.